← All stories
AI & Tech

Martin Shkreli says he expects no ‘AI relevant’ drug within the next 10 years

By Egleze Editorial Desk · Published October 13, 2026 · All-In Podcast · Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him
Martin Shkreli says he expects no ‘AI relevant’ drug within the next 10 years
All-In Podcast
All-In Podcast
Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him

What was said

"I don't think there'll be a single AI relevant drug in the next 10 years. Um AI does not help drug discovery. If you've ever built drugs, and raise your hand if you've made a drug, gotten FDA approval for a drug. Okay, I'm pretty sure that's it."

Martin Shkreli argues that AI will not materially advance drug discovery in the near term, saying he does not expect “a single AI relevant drug” in the next 10 years. He frames the view around his experience of taking a drug through FDA approval and says there is limited scope for AI to help in drug discovery.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Speaker
Martin Shkreli · guest
Programme
All-In Podcast
Episode
Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him
Clip time
15:56
Original source
Watch the source segment →
From this episode
All-In Podcast
All-In Podcast

Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him

October 12, 2026 · 25m · 2 Egleze moments
Read episode summary and key points →

More moments from this episode

PsychologyMartin Shkreli recalls status anxiety drove decisions he says led to prison→
More stories More from All-In Podcast